Gastric sleeve surgery is one of the most commonly performed bariatric procedures in the UK, offering a permanent, evidence-based solution for severe obesity. Also known as sleeve gastrectomy, the operation removes approximately 75–80% of the stomach, leaving a narrow, banana-shaped sleeve that restricts food intake and reduces hunger hormones. Recognised by the NHS and NICE as an effective long-term treatment, it is suitable for carefully selected patients who meet specific clinical criteria. This article explains how the procedure works, who qualifies, what to expect before and after surgery, the associated risks, and the alternatives available in the UK.

What Is Gastric Sleeve Surgery and How Does It Work

Gastric sleeve surgery removes 75–80% of the stomach laparoscopically, creating a banana-shaped sleeve that restricts food intake and reduces ghrelin production, promoting weight loss through both restriction and hormonal changes.

Have any more questions about this? Message our pharmaceutical team to get more info →

Gastric sleeve surgery, medically known as a sleeve gastrectomy, is a type of bariatric (weight-loss) surgery in which approximately 75–80% of the stomach is permanently removed, leaving a narrow, tube-shaped 'sleeve' roughly the size and shape of a banana. The procedure is performed laparoscopically (keyhole surgery) under general anaesthetic, typically taking between 60 and 90 minutes.

The mechanism by which gastric sleeve surgery promotes weight loss is twofold:

• Restriction: The significantly reduced stomach capacity means patients feel full after consuming much smaller portions of food.

• Hormonal changes: Removing a large portion of the stomach reduces production of ghrelin, often called the 'hunger hormone', which helps to decrease appetite. The procedure also appears to influence other gut hormones involved in appetite regulation and metabolism, including GLP-1 and PYY, though the full extent of these effects continues to be studied.

Unlike gastric bypass surgery, the gastric sleeve does not reroute the digestive tract, meaning food continues to pass through the stomach and intestines in the normal sequence. This makes it a somewhat simpler procedure with a lower risk of nutritional malabsorption, though vitamin and mineral supplementation remains important post-operatively.

Gastric sleeve surgery is considered a permanent intervention — the removed portion of the stomach cannot be restored. It is recognised by the NHS and NICE as an effective long-term treatment for severe obesity. According to NHS and National Bariatric Surgery Registry (NBSR) data, patients typically lose around 50–70% of their excess body weight within the first two years following surgery, though individual outcomes vary.

Who Is Eligible for Gastric Sleeve Surgery on the NHS

NHS eligibility follows NICE CG189 and typically requires a BMI of 40 or above, or 35–39.9 with a significant obesity-related condition, after non-surgical interventions have been tried and found insufficient.

Access to gastric sleeve surgery on the NHS is governed by criteria set out in NICE Clinical Guideline CG189 (Obesity: identification, assessment and management). Eligibility may vary slightly between commissioning bodies across the UK: Integrated Care Boards (ICBs) in England, Local Health Boards in Wales, NHS Health Boards in Scotland, and Health and Social Care Trusts in Northern Ireland.

Standard NHS eligibility criteria typically include:

• A Body Mass Index (BMI) of 40 or above, or

• A BMI of 35–39.9 alongside a significant obesity-related health condition such as type 2 diabetes, hypertension, obstructive sleep apnoea, or joint disease

• Evidence that all appropriate non-surgical weight management interventions have been tried and have not achieved or maintained adequate clinically beneficial weight loss

• Fitness for surgery and general anaesthetic

• Commitment to long-term dietary and lifestyle changes, including follow-up care

NICE CG189 also recommends that bariatric surgery should be considered as a first-line option for adults with a BMI of 50 or above. For adults with recent-onset type 2 diabetes (typically diagnosed within the past ten years), surgery should be considered as a first-line option if BMI is 35 or above, and may be considered at a BMI of 30–34.9 where other interventions have been insufficient. Lower BMI thresholds may also be appropriate for people of Asian family origin, who face higher cardiometabolic risk at lower BMI values.

Patients are typically assessed by a specialist multidisciplinary team (MDT) — including a bariatric surgeon, dietitian, psychologist, and specialist nurse — within a Tier 4 specialist bariatric service, usually following engagement with a Tier 3 specialist weight management programme.

It is worth noting that NHS waiting lists for bariatric surgery can be lengthy. Some patients choose to access surgery privately, where eligibility criteria may be more flexible, though the same clinical and safety standards should apply.

What to Expect Before, During and After the Procedure

Patients follow a liver-reducing diet for two to four weeks pre-operatively; surgery takes 60–90 minutes under general anaesthetic, with a one-to-two night hospital stay and a staged return to eating over six to eight weeks.

Preparation for gastric sleeve surgery is thorough and typically begins several months before the operation. Patients are usually required to follow a low-calorie or liver-reducing diet for two to four weeks prior to surgery. This helps shrink the liver, which overlies the stomach, making the procedure safer and technically easier for the surgical team. Pre-operative assessments include blood tests, cardiovascular evaluation, nutritional screening, and psychological assessment.

On the day of surgery, the procedure is carried out under general anaesthetic. The surgeon makes several small incisions in the abdomen and uses a laparoscope (a thin camera) alongside surgical instruments to remove the larger portion of the stomach and staple the remaining sleeve closed. Most patients spend one to two nights in hospital following the operation.

In the immediate post-operative period, patients can expect:

• Pain and discomfort around the incision sites, managed with prescribed analgesia

• A staged return to eating, beginning with clear fluids, progressing to pureed foods, then soft foods, before returning to a modified solid diet over approximately six to eight weeks

• Fatigue and reduced energy levels as the body adjusts

• Regular follow-up appointments with the bariatric team, including dietetic support

Protein and fluid targets are set by the bariatric dietitian and are individual to each patient; commonly, a minimum of 60 g of protein per day and 1.5–2 litres of fluid per day are recommended unless otherwise advised.

Most people are able to return to light activities within two to four weeks, though strenuous exercise and heavy lifting should be avoided for at least six weeks.

Ongoing monitoring of nutritional status is an essential part of post-operative care. In line with BOMSS (British Obesity & Metabolic Surgery Society) guidance, blood tests are typically performed at 3, 6, and 12 months after surgery, and then annually thereafter. These usually include a full blood count, urea and electrolytes, liver function tests, ferritin, vitamin B12, folate, vitamin D, calcium, and parathyroid hormone (PTH), alongside other tests as directed by the bariatric centre.

Risks, Complications and Long-Term Considerations

Short-term risks include staple line leakage and blood clots; long-term risks include gastro-oesophageal reflux, nutritional deficiencies, and weight regain, all requiring lifelong monitoring and follow-up with the bariatric team.

As with any major surgical procedure, gastric sleeve surgery carries risks, and patients should be fully informed before providing consent. The overall complication rate is relatively low when performed by experienced bariatric surgeons in accredited centres, but both short-term and long-term risks exist.

Short-term risks include:

• Bleeding or infection at the surgical site

• Leakage from the staple line — a serious but uncommon complication; UK data from the National Bariatric Surgery Registry (NBSR) suggest rates of approximately 1–2%, though this varies by centre and individual patient factors

• Blood clots (deep vein thrombosis or pulmonary embolism)

• Adverse reactions to anaesthesia

• Nausea and vomiting in the early recovery period

• Gallstones, which can develop during periods of rapid weight loss

Longer-term considerations include:

• Gastro-oesophageal reflux disease (GORD): Some patients experience worsening or new-onset acid reflux following a sleeve gastrectomy. Lifestyle measures and proton pump inhibitors (PPIs) may help; persistent or severe symptoms should be discussed with the bariatric team.

• Nutritional deficiencies: Deficiencies in vitamin B12, iron, vitamin D, calcium, folate, and other micronutrients can develop and require lifelong supplementation and monitoring.

• Strictures: Narrowing of the sleeve can occasionally occur and may require further intervention.

• Thiamine (vitamin B1) deficiency: This is a risk in patients with persistent vomiting. If prolonged vomiting or any neurological symptoms develop, urgent medical review is essential.

• Weight regain: A proportion of patients may regain some weight over time, particularly if dietary and lifestyle changes are not maintained.

• Psychological adjustment: Changes in body image and eating behaviour can be challenging; psychological support should be available as part of ongoing care.

When to seek emergency help: If you experience severe abdominal or chest pain, sudden breathlessness, a rapid heart rate, high temperature, or signs of a blood clot in the leg (swelling, redness, or pain in the calf), call 999 or attend your nearest A&E immediately. For other urgent concerns — such as persistent vomiting, signs of infection, or symptoms of nutritional deficiency (fatigue, hair loss, numbness, or tingling) — contact your bariatric team or call NHS 111 promptly.

If you are taking any medication as part of your weight management care and experience a suspected side effect, you can report this via the MHRA Yellow Card scheme at yellowcard.mhra.gov.uk. The same scheme can be used to report problems with any medical device.

Life After Gastric Sleeve Surgery: Diet and Lifestyle Changes

Long-term success requires small, frequent protein-rich meals, lifelong vitamin and mineral supplementation, regular blood monitoring, and at least 150 minutes of moderate physical activity per week.

Long-term success following gastric sleeve surgery depends significantly on sustained dietary and lifestyle changes. Surgery is a tool, not a cure — patients who engage actively with post-operative support programmes consistently achieve better outcomes in terms of weight loss and overall health improvement.

Dietary guidance following surgery typically includes:

• Eating small, frequent meals (five to six small portions per day) rather than three large meals

• Chewing food thoroughly and eating slowly to avoid discomfort and vomiting

• Prioritising protein-rich foods (lean meat, fish, eggs, dairy, legumes) to preserve muscle mass

• Avoiding high-sugar and high-fat foods, which can cause discomfort and hinder weight loss

• Separating fluids from meals — drinking between meals rather than with food — to avoid overfilling the sleeve

• Avoiding or limiting carbonated drinks and high-sugar beverages

• Being cautious with alcohol: absorption may be faster and more pronounced after sleeve gastrectomy, and alcohol can contribute to nutritional deficiencies and weight regain

Lifelong vitamin and mineral supplementation is essential. In line with BOMSS guidance, this typically includes a complete multivitamin and mineral supplement, vitamin D and calcium, iron (particularly important for individuals who menstruate), and vitamin B12 (often given as intramuscular injections every three months, or as high-dose oral supplementation). Additional supplements may be recommended based on individual blood test results. Adherence to supplementation and regular monitoring cannot be overstated.

Pregnancy and contraception: Women of childbearing age are strongly advised to avoid pregnancy for at least 12–18 months after surgery, as rapid weight loss during this period can affect foetal development. Effective contraception should be used during this time. When planning a pregnancy after bariatric surgery, a higher-dose folic acid supplement (5 mg daily) is recommended preconceptually and in early pregnancy. Care should be shared between the bariatric team and obstetric services throughout pregnancy.

Physical activity is strongly encouraged and plays a vital role in maintaining weight loss and improving cardiovascular health. Patients are typically advised to build up gradually, aiming for at least 150 minutes of moderate-intensity activity per week in line with NHS physical activity guidelines.

Emotional and psychological wellbeing should not be overlooked. Some individuals find that changes in their relationship with food, body image, or social eating require ongoing support. Access to a bariatric psychologist or support group — many of which are available through NHS bariatric services or patient organisations such as BOMSS — can be invaluable.

Alternatives to Gastric Sleeve Surgery Available in the UK

Surgical alternatives include Roux-en-Y gastric bypass and adjustable gastric band; non-surgical options include semaglutide (Wegovy), orlistat, intragastric balloon, and specialist Tier 3 weight management programmes.

Gastric sleeve surgery is one of several weight management options available in the UK, and it is not suitable or appropriate for everyone. A range of alternatives — both surgical and non-surgical — exist and may be recommended depending on individual clinical circumstances. The most appropriate option is determined by the specialist MDT in discussion with the patient.

Surgical alternatives include:

• Roux-en-Y Gastric Bypass: An established bariatric procedure that both restricts stomach size and reroutes the small intestine, resulting in significant weight loss and metabolic benefits, particularly for type 2 diabetes. It carries a higher risk of nutritional malabsorption than sleeve gastrectomy. The choice between bypass and sleeve is made on an individual basis by the MDT and patient.

• Adjustable Gastric Band: A silicone band is placed around the upper stomach to restrict food intake. It is reversible and adjustable but has fallen out of favour in many UK centres due to higher rates of long-term complications and less durable weight loss compared with sleeve or bypass procedures.

• One-anastomosis gastric bypass (OAGB) and biliopancreatic diversion with duodenal switch: These procedures are offered in selected UK centres for specific clinical indications and carry their own risk and benefit profiles; they are discussed on an individual basis by the MDT.

Non-surgical alternatives include:

• Intragastric balloon: A deflated balloon is inserted endoscopically into the stomach and inflated with saline, reducing stomach capacity. It is a temporary measure (typically in place for six months) and is not currently routinely funded by the NHS.

• Pharmacological therapy: Orlistat is available on the NHS to support weight loss in eligible patients. Semaglutide (Wegovy) has demonstrated significant weight loss efficacy and is approved by NICE (Technology Appraisal TA875) for use in specialist Tier 3 and Tier 4 NHS weight management services. Eligibility requires a BMI of 35 or above (or 30–34.9 in certain circumstances) alongside at least one weight-related comorbidity. Treatment is usually for a maximum of two years, in conjunction with a reduced-calorie diet and increased physical activity. Semaglutide should only be initiated and monitored within a specialist service. Suspected side effects should be reported via the MHRA Yellow Card scheme.

• Structured lifestyle programmes: Tier 3 specialist weight management services offer intensive dietary, behavioural, and physical activity support and are often a prerequisite before surgical referral.

Discussion with a GP or specialist is essential to determine the most appropriate pathway based on individual health needs, preferences, and clinical history.

Frequently Asked Questions